Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00245310
Status:
COMPLETED
Last Update Posted:
2010-10-11
First Post:
2005-10-25
Brief Title:
Indocyangreen Elimination in Cirrhosis and Acute Liver Failure
Sponsor:
Heidelberg University
Organization:
Heidelberg University
Study Overview
Official Title:
Evaluation of the Indocyangreen Elimination as a Prognostic Marker in Decompensated Cirrhosis and Acute Liver Failure
Status:
COMPLETED
Status Verified Date:
2008-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Indocyangreen ICGis totally biliary eliminated and corresponds to hepatocyte function and liver perfusion
The ICG-clearance will be evaluated as a prognostic marker in liver disease
The ICG-clearance will be evaluated as a prognostic marker in liver disease
Detailed Description:
patients with acute liver failure or advanced liver disease will be studied ICG-clearance will be correlated with established clinical scores and outcome
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None